How to Get Finasteride in Washington State

What Is Finasteride and Why Do Washington Residents Seek It?

Finasteride is a 5-alpha reductase type II inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT), the androgen responsible for follicle miniaturization in androgenetic alopecia (AGA) and prostate tissue proliferation in benign prostatic hyperplasia (BPH). The FDA approved the 1 mg dose for male pattern hair loss in 1997 and the 5 mg dose for BPH in 1992. [1][2]

Washington State has a large and growing telehealth market, and finasteride is among the most frequently requested drugs on platforms licensed to prescribe there. Demand is driven partly by demographics: roughly 50% of men experience noticeable AGA by age 50, according to epidemiological data published in the Journal of Investigative Dermatology. [3] BPH affects approximately 50% of men in their 50s and up to 90% of men by their 80s per the American Urological Association guidelines referenced by the NIH. [4]

The drug is generic, inexpensive, and taken once daily by mouth, making it practical for long-term use. Those characteristics also make Washington an active market for 503A compounding pharmacies that offer finasteride in topical or combination formulations not commercially available.

Is Finasteride Legal to Prescribe via Telehealth in Washington?

Yes. Washington State explicitly permits telehealth prescribing of finasteride. Washington's Uniform Disciplinary Act and the Washington State Department of Health's telehealth policy allow licensed prescribers to issue controlled and non-controlled prescriptions after a synchronous or asynchronous visit that establishes a valid patient-provider relationship. Finasteride is not a controlled substance, which removes the additional federal restrictions that apply to drugs like testosterone. [5]

The Washington Medical Commission confirms that a prescriber may conduct a history and physical assessment via two-way audio-visual technology and issue a prescription without an in-person examination, provided the standard of care is met. [6] NPs and PAs licensed in Washington hold independent or collaborative prescriptive authority and may prescribe finasteride within their scope.

Platforms currently licensed to operate in Washington include national telehealth providers that staff Washington-licensed clinicians. Patients complete an intake form, upload photographs of the scalp or provide symptom history, and receive a clinical review. Asynchronous models, where the provider reviews the case and responds within 24 hours, are common for finasteride because the drug's safety profile is well established and physical exam findings are limited for AGA. [7]

What Clinical Evidence Supports Finasteride Use?

The evidence base for finasteride in AGA is strong and spans more than 25 years of post-approval data.

Kaufman et al. (J Am Acad Dermatol 1998, N=1,553) showed that finasteride 1 mg daily produced a statistically significant increase in hair count at 1 year compared to placebo, and 83% of men maintained or increased hair count at 2 years versus 28% on placebo (P<0.001). [8] That trial remains the most-cited phase III dataset for the 1 mg indication.

A 5-year open-label extension of the key finasteride trials found that men who continued treatment maintained hair count above baseline, while those switched to placebo experienced progressive loss, confirming that the drug's benefit depends on continued use. [9]

For BPH, the Medical Therapy of Prostatic Symptoms (MTOPS) trial (N=3,047) demonstrated that finasteride reduced the risk of overall BPH clinical progression by 34% compared to placebo over a median of 4.5 years. [10] Combination therapy with doxazosin reduced risk by 67%, establishing finasteride as a first-line agent for moderate-to-severe BPH in men with enlarged prostates. [11]

The FDA label updated in 2011 added language about post-finasteride syndrome and persistent sexual side effects, though the European Medicines Agency review (2020) noted that serious persistent adverse events are rare and causality in many case reports remains uncertain. [12] Sexual side effects, including reduced libido and erectile dysfunction, occur in roughly 1.4 to 3.8% of men in randomized trials and are reversible upon discontinuation in the majority of cases per the FDA prescribing information. [1]

How to Get a Finasteride Prescription in Washington: Step by Step

Getting finasteride in Washington follows a predictable sequence regardless of whether you choose telehealth or an in-person visit.

Step 1. Choose your care pathway. Telehealth is appropriate for most men seeking AGA treatment because the diagnosis is primarily visual and symptomatic. Men with urinary symptoms suggestive of BPH, prostate cancer risk factors, or a PSA above 1.0 ng/mL may benefit from an in-person urology or primary care visit first. The American Urological Association recommends baseline PSA measurement before starting finasteride for BPH because the drug lowers PSA by approximately 50% at 6 to 12 months, which can affect cancer screening interpretation. [13]

Step 2. Complete the intake assessment. Telehealth platforms collect a structured medical history including current medications, sexual health baseline, family history of prostate cancer, and a scalp photo series. In-person visits add a scalp exam and may include dermatoscopy. The history should document Norwood-Hamilton scale classification for AGA or International Prostate Symptom Score (IPSS) for BPH. [4]

Step 3. Review and consent. Your provider will discuss the benefit-risk profile, confirm you understand the PSA effect, and obtain informed consent. The FDA label requires that women who are or may be pregnant not handle crushed finasteride tablets due to the risk of feminization of a male fetus. [1]

Step 4. Prescription transmitted. Washington pharmacies accept electronic prescriptions. Your provider sends the Rx to your preferred pharmacy or a mail-order service. Most telehealth platforms complete this within 24 hours of your consult. [7]

Step 5. Fill and begin. Generic finasteride 1 mg is available at Walgreens, Rite Aid, Costco, and Fred Meyer locations across Washington. GoodRx prices in Seattle and Spokane range from roughly $10 to $28 for a 30-day supply as of mid-2025. Mail-order 90-day supplies cost less per unit. 503A compounding pharmacies can fill prescriptions for topical finasteride 0.1% or finasteride/minoxidil combination formulations if your provider writes for those.

What Labs Are Needed Before Starting Finasteride in Washington?

Lab requirements vary by indication and provider.

For AGA in otherwise healthy men under 40 with no urinary symptoms, many Washington telehealth providers prescribe finasteride 1 mg without mandatory baseline labs. That approach aligns with standard practice given the drug's safety profile in young men with no comorbidities. [8]

For BPH or for men over 40, the standard workup includes a PSA test and, ideally, a digital rectal exam or urology referral. Because finasteride suppresses PSA by roughly 50% after 6 to 12 months of therapy, a baseline value is clinically necessary for meaningful cancer screening going forward. A man's PSA should be doubled to correct for finasteride's effect when interpreting results during treatment, per the AUA guideline on early detection of prostate cancer. [13]

Some providers also check a basic metabolic panel and testosterone level to rule out secondary causes of hair loss and to establish a baseline, particularly if the patient is also considering minoxidil or androgen therapy. The Endocrine Society does not mandate labs before finasteride for AGA but does recommend them when the diagnosis is uncertain. [14]

Thyroid function (TSH) testing is reasonable when diffuse hair loss is present rather than the vertex and frontotemporal pattern typical of AGA, since hypothyroidism is a common reversible cause of hair thinning. [15]

Washington Medicaid and Insurance Coverage for Finasteride

Washington's Apple Health (Medicaid) covers finasteride 5 mg for BPH with prior authorization. The prior authorization criteria typically require documentation of BPH diagnosis (ICD-10 N40.1), a qualifying IPSS score, and confirmation that the patient has not responded adequately to alpha-blockers alone when combination therapy is requested. [16]

Finasteride 1 mg for AGA is generally not covered by Washington Medicaid or most commercial plans because AGA is classified as cosmetic. A small number of commercial plans with expanded formularies cover 1 mg, so checking your Explanation of Benefits is worthwhile before paying out of pocket.

The Washington Health Benefit Exchange (Healthplanfinder) plans follow similar coverage logic. Employer-sponsored plans in Washington are governed by ERISA and vary widely; your HR department or plan formulary document is the authoritative source. [17]

For patients without coverage, manufacturer coupons for Propecia (brand finasteride, Merck) are available but the generic is substantially cheaper. GoodRx, Mark Cuban Cost Plus Drugs, and NovaBay programs can reduce generic finasteride 1 mg to $10, $15 per month at most Washington chain pharmacies.

503A Compounding Pharmacies in Washington

Washington State has licensed 503A pharmacies that can compound finasteride in formulations not available commercially, such as topical finasteride 0.1% solution, finasteride plus minoxidil topical combinations, and oral capsules at non-standard doses. A 503A pharmacy compounds for individual patients based on a valid prescription; it does not compound in bulk for resale, which is the province of FDA-registered 503B outsourcing facilities. [18]

The Washington State Department of Pharmacy regulates 503A pharmacies under RCW 18.64 and WAC 246-878. A pharmacy must be licensed in Washington and comply with USP standards for compounding. Your telehealth or in-person provider writes the prescription to the specific compounding pharmacy, which then ships directly to your Washington address. [19]

Topical finasteride has attracted interest because small studies suggest it may achieve scalp-tissue concentrations comparable to oral dosing with lower systemic DHT suppression, potentially reducing sexual side effects, though head-to-head comparative data are limited. A 2018 study in JEADV (N=323) found topical finasteride 0.005% gel applied daily was non-inferior to oral finasteride 1 mg in hair count increase at 24 weeks. [20] That study is preliminary and the formulation differs from the 0.1% commonly compounded in the U.S., so direct comparison is imprecise.

Who Can Prescribe Finasteride in Washington?

Washington State authorizes several provider types to prescribe finasteride.

Medical doctors (MD) and doctors of osteopathic medicine (DO) licensed by the Washington Medical Commission may prescribe finasteride without restriction. Nurse practitioners (ARNP) in Washington hold full independent practice authority under RCW 18.79 and may prescribe finasteride within their scope without physician oversight, a policy Washington adopted definitively in 2023. [6] Physician assistants (PA) in Washington practice under RCW 18.71A and may prescribe finasteride under a practice agreement, though collaborative, not supervisory, agreements have been the norm since 2023 PA practice reforms.

Naturopathic physicians (ND) licensed under RCW 18.36A hold prescriptive authority for certain legend drugs in Washington; whether a specific ND's scope includes finasteride depends on their individual license endorsements. Confirm prescriptive scope before booking with an ND.

Telehealth platforms often staff ARNPs and PAs as primary reviewers, which is clinically appropriate for finasteride given the straightforward pharmacology. Every prescription from a Washington-licensed provider carries the same legal validity regardless of the prescriber's degree. [7]

Transferring an Existing Finasteride Prescription to Washington

If you hold a finasteride prescription from another state and move to Washington, or if you want to switch pharmacies within Washington, the process is straightforward.

Federal law and Washington pharmacy regulations allow a pharmacist to transfer a valid finasteride prescription from one pharmacy to another, including across state lines for drugs not designated as controlled substances. Finasteride is Schedule V in some state schedules for unrelated historical reasons in certain jurisdictions, but in Washington it is not a scheduled drug, removing transfer restrictions. [5]

To transfer, call the receiving pharmacy with the name and phone number of the originating pharmacy. The pharmacist at the receiving pharmacy contacts the originating pharmacy directly. The original prescription is voided at the origin and filled at the new location. Electronic prescription systems make this process faster; most Washington chain pharmacies complete transfers within a business day.

If your out-of-state prescriber's license is not valid in Washington, you will need a new prescription from a Washington-licensed provider. A telehealth consult typically takes 24 to 48 hours, less time than most pharmacy transfers. [7]

What to Expect After Starting Finasteride

Finasteride's mechanism requires time to manifest clinically. DHT suppression begins within days of the first dose, reaching nadir serum DHT levels by 2 weeks. [1] Hair follicle response is slower because follicle cycling operates on months-long timescales.

Most men see early changes at 3 to 6 months, primarily a reduction in shedding. Shedding may temporarily increase in the first 4 to 8 weeks as follicles shift from a prolonged telogen phase into anagen, a phenomenon called a shed phase. This is expected and does not indicate the drug is not working. [8]

Meaningful visible improvement typically appears at 6 to 12 months. The Kaufman 1998 trial data showed that hair count improvement continued from month 12 to month 24, meaning patients who only assess at 3 to 4 months may underestimate the drug's eventual benefit. [8] Stopping finasteride results in loss of the gained and preserved hair within 6 to 12 months as DHT returns to baseline levels. [9]

PSA levels fall by approximately 50% at 6 months of treatment and remain suppressed with continued use. Any PSA rise during treatment should prompt clinical evaluation because a rise from, say, 1.2 to 1.9 ng/mL represents roughly a 4× increase after correction, equivalent to a PSA doubling from 2.4 to 3.8 in an untreated man. [13]

Drug Interactions and Contraindications Relevant to Washington Prescribers

Finasteride has a limited drug interaction profile compared to many chronic medications. The drug is metabolized by CYP3A4, so potent CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin) may raise finasteride plasma concentrations, though no dose adjustment is currently specified in the FDA label because the magnitude of interaction is modest. [1]

Combining finasteride with alpha-blockers such as tamsulosin or doxazosin, as in the MTOPS trial protocol, is clinically common for BPH and does not require special monitoring beyond standard blood pressure assessment. [10] Combination with dutasteride, a dual 5-alpha reductase inhibitor, is not standard; both drugs reduce DHT through overlapping mechanisms and the combination is not FDA approved.

Absolute contraindications: finasteride is contraindicated in women who are pregnant or may become pregnant (Category X) due to risk of hypospadias and ambiguous genitalia in male fetuses. [1] This contraindication applies to handling of crushed tablets. Women with AGA or hirsutism who are not pregnant and are using reliable contraception have been prescribed finasteride off-label; that decision falls outside the scope of this Washington access guide but is addressed in Endocrine Society guidelines. [14]

Men with a history of prostate cancer should discuss finasteride use with their urologist, as finasteride was associated with a small increase in high-grade prostate cancer in the Prostate Cancer Prevention Trial (PCPT, N=18,882), though the absolute risk increase was small and the overall finding remains debated. [21]